KRT18 and metabolic dysfunction-associated steatotic liver disease: If the patients were stratified according to the cytokeratin 18 fragment (CK-18) level, an established marker for liver fibrosis and increased inflammatory activity, only Th17/rTreg ratio differentiated between early and advanced stages of MASLD.